The implications of the EU ban on titanium dioxide: A comprehensive review of safety concerns and alternatives
Annales Pharmaceutiques Françaises · 2025-05 · 83 (3) · 438-444
DOI: 10.1016/j.pharma.2024.11.002 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Annales Pharmaceutiques Françaises, 2025-05. Verfasst von Varsha Pokharkar und 3 weiteren Autor:innen. Beteiligte Einrichtung: BVDU Poona College of Pharmacy, Pune, Maharashtra, India. Electronic address: varsha.pokharkar@bharatividyapeeth.edu. Hauptthemen laut MEDLINE: Titanium. Die Arbeit wurde bisher 13-mal zitiert (Crossref) und nennt 34 Literaturangaben.
Abstract (Originalsprache)
Titanium dioxide, a naturally occurring compound, has been extensively utilized across various industries such as food, pharmaceuticals, and cosmetics. In the food sector, it was commonly employed as a color and opacity enhancer under the designation E171. However, due to safety concerns, the EU has prohibited its use as a food additive, effective August 2022, following a six-month transition period. The decision was based on scientific research highlighting risks associated with inhaling titanium dioxide nanoparticles and its potential genotoxic effects. This review also summarizes the implications of this ban on the pharmaceutical industry, where titanium dioxide is utilized in drug manufacturing. While the safety of titanium dioxide in tablets remains inconclusive, the EU's regulatory action has prompted a closer examination of alternative options. While alternatives exist, they may not provide the same benefits as TiO2, particularly in pharmaceuticals. Further research is needed to determine the safety and effectiveness of TiO2 and its alternatives in these applications.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- BVDU Poona College of Pharmacy, Pune, Maharashtra, India. Electronic address: varsha.pokharkar@bharatividyapeeth.edu.
- BVDU Poona College of Pharmacy, Pune, Maharashtra, India. Electronic address: sejalchandak088@gmail.com.
- BVDU Poona College of Pharmacy, Pune, Maharashtra, India. Electronic address: pawarrutika427@gmail.com.
- BVDU Poona College of Pharmacy, Pune, Maharashtra, India. Electronic address: akshay.khandke@bharatividyapeeth.edu.
Zitieren
APA
Pokharkar, V., Chandak, S., Pawar, R., & Khandke, A. (2025). The implications of the EU ban on titanium dioxide: A comprehensive review of safety concerns and alternatives. Annales Pharmaceutiques Françaises, 83(3), 438-444. https://doi.org/10.1016/j.pharma.2024.11.002
Vancouver
Pokharkar V, Chandak S, Pawar R, Khandke A. The implications of the EU ban on titanium dioxide: A comprehensive review of safety concerns and alternatives. Annales Pharmaceutiques Françaises. 2025;83(3):438-444. doi:10.1016/j.pharma.2024.11.002
BibTeX
@article{Pokharkar2025,
author = {Pokharkar, Varsha and Chandak, Sejal and Pawar, Rutika and Khandke, Akshay},
title = {The implications of the EU ban on titanium dioxide: A comprehensive review of safety concerns and alternatives},
journal = {Annales Pharmaceutiques Françaises},
year = {2025},
volume = {83},
number = {3},
pages = {438--444},
doi = {10.1016/j.pharma.2024.11.002}
}
EUVIMED